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Synthesis and structural characterisation of
bismuth(III) hydroxamates and their activity
against Helicobacter pylori†
Amita Pathak,a Victoria L. Blair,a Richard L. Ferrero,b Peter C. Junk,c Richard F. Tabora
and Philip C. Andrews*a
Seven new bismuth(III) hydroxamate complexes derived from the hydroxamic acids N-methyl-
furohydroxamic acid (H-MFHA), N-benzoyl-N-phenylhydroxamic acid (H-BPHA), salicylhydroxamic acid
(H2-SHA), benzohydroxamic acid (H2-BHA), and acetohydroxamic acid (H2-AHA) have been synthesized
and characterized. The complexes formed are either tris-hydroxamato complexes containing only mono-
anionic ligands, [Bi(H-SHA)3], [Bi(MFHA)3] and [Bi(BPHA)3]; mixed-anion complexes, [Bi(SHA)(H-SHA)] and
[Bi(AHA)(H-AHA)]; and potassium bismuthate complexes, K[Bi(SHA)2] and K[Bi(BHA)2]. The solid-state
structure of three complexes has been determined through single crystal X-ray diffraction;
[Bi(MFHA)3]2·Me2CvO, {[Bi(SHA)(H-SHA)(DMSO)2][Bi(SHA)(H-SHA)(DMSO)]·DMSO}∞ and [Bi(BPHA)3]2·
2EtOH. All the complexes and their parent acids were assessed for the bactericidal activity against three
strains of Helicobacter pylori (26695, B128 and 251). Of the acids, only acetohydroxamic acid showed any
activity at low concentrations (MIC 6.25 μg mL−1; 83.26 μM) while the others were not toxic below 25 μg
mL−1. In contrast, their bismuth(III) complexes all showed excellent activity across all three strains (e.g.
0.28 μM for [Bi(H-SHA)3] to 6.01 μM for K[Bi(BHA)2] against strain 251) with only minor variations in activity
being both ligand and composition dependant.
Introduction
Hydroxamic acids are a class of compound with general
formula RCON(H)OH and are of significant biological impor-
tance. Principally known as strong polyfunctional iron chela-
tors they also display antibacterial, anti-inflammatory and
anti-asthmatic behaviour,1,2 and have been used in the design
of therapeutic targets for cancer,3,4 Alzheimer’s disease,5 haemo-
chromatosis,6,7 and malaria.8 Being diprotic, deprotonation
can occur at either the NH or OH functionality or at both,
though they are much weaker acids than analogous carboxylic
acids RC(vO)OH. In addition to Fe(III), anions derived from
hydroxamic acids are known to chelate to various metal ions,
including heavy metals.1,9,10 They are biochemically significant
in that they form constitutive parts of active sites of
some enzymes.11 Their significance is also enhanced by
their involvement in biological processes such as microbial
iron transport,11 inhibition of the nickel-dependent
urease enzymes12–15 and the zinc-dependent matrix
metalloproteinases.16
The mode-of-action of metal compounds in exerting a bac-
tericidal or bacteriostatic effect is under-researched and poorly
understood. There are general known effects: generation of
radical oxygen species and anti-oxidant depletion, interference
in cell redox processes, enzyme and ATP inhibition, disruption
of protein function, membrane impairment, and DNA
damage.16,17 One of the key processes is ion mimicry, particu-
larly of Fe(III). This is relevant for metals in the +III oxidation
state, such as bismuth. The biological chemistry of Bi(III) inter-
sects well with that of Fe(III), though Bi(III) is significantly more
thiophilic.18 Bismuth(III) has a strong affinity for S-based
ligands, such as glutathione and metallothionein, but also
competes with ferric ions in vivo at N- and O-binding sites in
biomolecules.19 for example with transferrin and lactoferrin in
human serum.20 The few metallomic studies on bismuth
relate almost exclusively to H. pylori,21 primarily because
bismuth compounds (subsalicylate and citrate salts) are highly
effective and used clinically in the treatment and eradication
of H. pylori.22 Recent studies have begun to uncover mecha-
nisms by which bismuth is toxic to the bacterium, including
disrupting the enzymes urease and alcohol dehydrogenase,
and interfering with Fe(III) regulating proteins.23
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To survive, many bacteria rely on siderophores (polydentate
O-binding molecules with carboxylate, catecholate and
hydroxamate functional groups) as strong metal chelators to
sequester and transport ferric ions.24 Targeting bismuth
hydroxamates provides the potential to develop new antibacter-
ial compounds and strategies – using siderophores as ‘trojan
horses’ for the uptake of Bi(III) into a microbial cell.17
Since H. pylori does not use siderophores to take up iron,
and instead utilizes host transferrin, lactoferrin and heme, our
recent study on the strong bactericidal effect of bismuth(III)
benzohydroxamates against H. pylori also suggests iron
mimicking processes could be highly effective.25 In this study,
the first on bismuth hydroxamates, we demonstrated that
mono- and di-anionic hydroxamato complexes derived from
benzohydroxamic acid (H2-BHA); [Bi2(BHA)3], [Bi(H-BHA)3]
and [Bi(BHA)(H-BHA)], displayed nM activity against H. pylori,
orders of magnitude greater that standard bismuth carboxylate
based medications. The hydrolytic instability of the complexes
was also demonstrated with the crystallization and structural
elucidation of the first Bi34 oxido-cluster [Bi34O22(BHA)22-
(H-BHA)14(DMSO)6].
26
In this paper we now report the results of our extended
study into the formation, structure and bactericidal activity
of a series of novel bismuth(III) hydroxamates derived from
N-methylfurohydroxamic acid (H-MFHA), N-benzoyl-N-phenyl-
hydroxamic acid (H-BPHA), salicylhydroxamic acid (H2-SHA),
and acetohydroxamic acid (H2-AHA), shown in Fig. 1. In
addition, a study of the K salt of the anionic benzohydroxamate
bismuthate complex [Bi(BHA)2] is also now included. Three com-
plexes have been structurally authenticated by single crystal X-ray
diffraction; [Bi(MFHA)3]2·Me2CvO (3·0.5Me2CvO), {[Bi(SHA)-
(H-SHA)(DMSO)2][Bi(SHA)(H-SHA)(DMSO)]·DMSO}∞ (4·(DMSO2)),
and [Bi(BPHA)3]2·2EtOH (7·EtOH). The activity of the com-
plexes towards three strains of H. pylori and their toxicity
towards human fibroblast cells is also reported and discussed.
Results and discussion
The five target hydroxamic acids (Fig. 1) were chosen to
provide structural diversity in the composition of the Bi(III)
complexes and also differences in possible binding modes and
coordination environments. Acetohydroxamic acid is already
known to inhibit the Ni-centred urease in H. pylori and so was
an obvious target.27 The others provide varying protic sites
for anion formation and donor atoms for intra- and inter-
molecular bonding with the metal centre.
The acids were treated with BiPh3 in a stoichiometric ratio
of 3 : 1 under both solvent-free (SF) and solvent-mediated (SM)
conditions (Scheme 1). For the solvent free reaction the thermo-
chemical profile of the protolysis reaction was first studied
using differential scanning calorimetry (DSC) to establish
whether the reaction proceeded and at which temperature.
This DSC profiles indicated that solvent free reactions were
possible with exotherms for N-methylfurohydroxamic acid
(H-MFHA), salicyhydroxamic acid (H2-SHA) and benzohydrox-
amic acid (H2-BHA) at 100, 120 and 60 °C respectively. Grind-
ing the acid together with crystalline BiPh3 and heating under
a nitrogen atmosphere to just above the required temperature
produced good yields of the target mono-anionic tris-hydrox-
amato complexes: [Bi(H-SHA)3] 1, [Bi(H-BHA)3] 2 and [Bi-
(MFHA)3] 3. We have reported previously on the formation and
analysis of [Bi(H-BHA)3].
26 Interestingly, N-benzoyl-N-phenyl-
hydroxamic acid (H-BPHA, pKa 9.15) and acetohydroxamic acid
(H2-AHA, pKa 9.40), were more problematic and no single isol-
able product could be obtained. Of the five hydroxamic acids
these two have the highest reported pKa values. The DSC
profiles showed exotherms at much higher temperatures. With
(H2-AHA) and BiPh3 the component endothermic melting
points are observed at 61 and 81 °C respectively, followed then
by two exotherms at 193 and 200 °C. With (H-BPHA) and BiPh3
the melting endotherms are observed at 78 and 110 °C respecti-
vely, and then a large broad exotherm beginning at 167 °C and
finishing at 220 °C. These high reaction temperatures most
likely mean product formation by this method is not homo-
geneous and is accompanied by decomposition.
Analogous solvent-mediated reactions conducted in either
ethanol or toluene at reflux over 24 h produced the same result.
Yieldsforeachreactionweremarginally improvedwhenconducted
in toluene (58–63%) rather than ethanol (55–57%), but were both
lowerthanfortheequivalentsolvent-freereactions(65–69%).
Fig. 1 Hydroxamic acids employed in the formation of bismuth(III)
complexes.
Scheme 1 Synthetic pathways to bismuth(III) hydroxamate complexes
1, 2, 4–6, 8, and 9. (i) = solvent-free (80–120 °C); (ii) = solvent reflux in
ethanol or toluene; (iii) = THF, −78 °C to RT.
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Bismuth tert-butoxide behaves as a stronger base than
BiPh3 and was expected to react with the hydroxamic acids in a
less selective manner. Reactions were conducted under inert
conditions by adding a dry THF solution of Bi(OtBu)3 to the
hydroxamic acid in THF cooled to −78 °C. The reaction
mixture was then allowed to warm slowly to room temperature
overnight. All volatiles were then removed in vacuo and the
remaining product washed with dry EtOH, which was sub-
sequently removed by filtration. In the absence of any knowl-
edge of the hydrolytic stability of the resultant Bi(III)
hydroxamates analyses were conducted using inert atmosphere
protocols. The compounds were subsequently exposed to air
and moisture and re-analysed.
The diprotic hydroxamic acids, (H2-SHA), (H2-AHA) and
(H2-BHA), resulted in mixed-anion complexes: [Bi(SHA)(H-SHA)]
4, [Bi(AHA)(H-AHA)] 5, and [Bi(BHA)(H-BHA)] 6. Notably, the
third accessible proton on the salicylate anion was not
removed. The monoprotic acids (H-MFHA) and (H-BPHA)
resulted in the tris-hydroxamato species; [Bi(MFHA)3] 3 and
[Bi(BPHA)3] 7 (Scheme 2).
The dianionic complexes retain an acidic N–H on one of the
ligands. In targeting more hydrophilic bismuthate complexes of
form K[BiL2], each dianionic complex was treated with one equi-
valent of K(OtBu) using reaction conditions similar to those
under which they were initially formed. This resulted in the for-
mation and isolation of two novel potassium bismuthate com-
plexes; K[Bi(SHA)2] 8 and K[Bi(BHA)2] 9. The reaction with Bi
(AHA)(H-AHA)] 5 produces only an insoluble compound which
does not analyse as the pure target complex but as a mixture.
Compound characterisation
The solution state structures of complexes 1–7 were studied by
1H-NMR and 13C-NMR spectroscopy in d6-DMSO as solvent. A
summary of key chemical shifts for the acids and bismuth(III)
complexes are presented in Table 1. In the 1H NMR spectra of
the acids the NH and OH proton resonances are averaged,
giving broad singlets. The formation of the hydroxamato
bismuth(III) complexes is confirmed by the absence of the
chemical shifts associated with one or both of these hydrox-
amic OH and/or NH protons following deprotonation with
BiPh3 or Bi(O
tBu)3. In those complexes where there is a
residual NH proton, the signal for this is observed at a higher
frequency relative to the averaged signal observed for the acid.
Thus, in 1 and 4 the NH proton is observed at δ 11.96 and
12.20 respectively (from δ 11.66), while in 5 and 6 they are
found at δ 11.62 (from 9.71) and δ 12.20 (from 10.14) respecti-
vely. The interesting spectrum is that of 2 in which two dis-
tinct proton signals are observed at δ 11.14 and 9.02, each
integrating to 0.5H. This could result from a configurationally
stable tautomerism in the hydroxamato anion, PhC(vO)N(H)–
O− and PhC(–OH)vN–O−. In the absence of solid-state struc-
tural information it can only be speculated that this results
from the ligand being more labile but with a slow interconver-
sion rate caused by binding with the Bi atom.
The main structural diagnostic in the 13C NMR spectra for
the various complexes would be the presence of CvO or CvN.
Unfortunately in d6-DMSO at 25 °C these resonances appear
indistinguishable, presenting only as a single averaged signal.
However, some general observations can be made. Where the
CvO is retained on deprotonation of the acid – in 3 and 7 –
there is a low frequency shift for the carbonyl C of
ca. 4–5 ppm. Though this is less pronounced in 1 and 2 and is
perhaps expected in 2 because of the appearance of suspected
tautomeric forms. In those complexes where the only form of
the ligand is a dianion – in 8 and 9 – the rearrangement to a
CvN bond results in a noticeable high frequency shift for the
new imino C of ca. 3–4 ppm. Complexes 4, 5 and 6 contain
both a dianionic and mono-anionic ligand and show only
minor shifts away from the carbonyl C chemical shift
(+0.2 ppm in 4, −2.4 ppm in 5, and +0.9 ppm in 6) reflecting
competing influences of CvO vs. CvN.
A summary of the key IR absorbances relating to each
bismuth complex and comparing them with the parent hydro-
xamic acid is provided as Table S1 in the ESI.† Complexes 1, 2,
4, 5 and 6 show evidence of a residual NH bond in the hydrox-
amate anions, while absorbances relating to the acid OH
stretch disappears for each and every complex. The shift to
lower wavenumber for the NH stretching band is more pro-
nounced in the mixed-anion hydroxamato complexes (4, 5,
Scheme 2 Synthesis of bismuth(III) hydroxamate complexes 3 and 7.
(i) = solvent-free (80–120 °C); (ii) = solvent reflux in ethanol or toluene;
(iii) = THF, −78 °C to RT.
Table 1 Summary of key diagnostic 1H and 13C NMR chemical shifts
observed for bismuth(III) hydroxamate complexes 1–9 (X = O and/or N)
N–H O–H C(vX)
H2-SHA 11.66 (2H) 166.2
[Bi(H-SHA)3] 1 11.96 — 166.3
[Bi(SHA)(H-SHA)] 4 12.21 — 166.4
K[Bi(SHA)2] 8 — — 170.2
H2-BHA 10.14 (2H) 164.2
[Bi(H-BHA)3]
21 2 11.14 (0.5H) 9.02 (0.5H) 164.6
[Bi(BHA)(H-BHA)]21 6 12.48 — 165.3
K[Bi(BHA)2] 9 — — 167.8
H2-AHA 9.71 (2H) 167.0
[Bi(AHA)(H-AHA)] 5 11.62 — 164.4
(H-MFHA) — 10.24 158.3
[Bi(MFHA)3] 3 — — 153.7
H-BPHA — 10.69 167.8
[Bi(BPHA)3] 7 — — 163.8
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and 6) than in the mono-anionic tris-hydroxamato complexes
(1 and 2).
In the four hydroxamate complexes proposed to have
residual CvO bonds after anion formation (1, 2, 3 and 7) the
IR spectra indicate coordination of the carbonyl O atom to Bi,
as evidenced by the prominent shift to lower wavenumbers for
each. Each of these complexes also shows an absorbance
for the C–N bond which shifts slightly to a lower wavenumber
(ca. 10–20 cm−1). Indicative of dianion formation and
rearrangement, the spectra of complexes 4, 5, 6, 8 and 9 show
the appearance of pronounced absorbances for CvN bonds at
or close to 1595 cm−1 for each of these complexes.
Taking the IR and NMR data together along with the solid-
state structures of 3, 4 and 7 described below, we have
assigned the compound compositions provided in Schemes 1
and 2 above.
X-ray crystallography
Of the seven new bismuth(III) hydroxamate complexes, single
crystals suitable for X-ray diffraction studies were obtained
from solutions of 3, 4 and 7 in acetone, DMSO and ethanol/
acetone respectively. Complexes 3·0.5Me2CvO and 7·EtOH
contain two crystallographically independent molecules
without intermolecular interactions in the asymmetric unit.
A summary of the crystallographic data for all three com-
pounds is given in the Experimental section.
In both complexes 3·0.5Me2CvO and 7·EtOH the parent
hydroxamic acids have been deprotonated only at the hydroxyl
group to give the tris-hydroxamato complexes {[Bi(MFHA)3]2·
Me2CvO} (Fig. 2) and {[Bi(BPHA)3]2·2EtOH} (Fig. 3), with the
mono-anionic hydroxamate ligands bonding to the Bi(III)
atoms in a bi-dentate fashion through the carbonyl and hydrox-
amato O atoms to form 5-membered BiO2NC chelate rings.
The Bi–O bond lengths show asymmetry with the average
covalent bond length [2.2417 Å (3); 2.237 Å (7)] distinctly
shorter than the coordinative (dative) Bi–O carbonyl length
[2.4523 Å (3); 2.496 Å (7)]. In each asymmetric unit of
3·0.5Me2CvO and 7·EtOH the Bi(III) center is formally six co-
ordinate while dimerization of two monomeric units, through
the O atom of an adjacent hydroxamate ligand [Bi–O: 2.881(15)
Å (3); 2.779(16) Å (7)], increases the coordination number to
seven giving an overall distorted pentagonal bipyramidal
geometry.
X-ray crystallographic studies on crystals grown from a
DMSO solution of compound 4 confirmed the mixed mono-
and di-anionic hydroxamato complex {[Bi(SHA)(H-SHA)-
(DMSO)2][Bi(SHA)(H-SHA)(DMSO)]·DMSO}∞ [4(DMSO)1.5·
0.5DMSO] as shown in Fig. 4. The asymmetric unit consists of
two crystallographically independent molecules, essentially
isostructural, which differ only by the number of coordinated
DMSO solvent molecules (Bi(1) has one DMSO and Bi(2) has
two, as shown in Fig. 4), for brevity only Bi(2) will be discussed
in detail.
In the asymmetric unit of complex [4(DMSO)1.5·0.5DMSO]
the Bi(III) center bonds to one doubly deprotonated hydrox-
amate ligand and one mono-deprotonated hydroxamate ligand
through the carbonyl and hydroxamate O atoms with the
remainder of the coordination sphere filled by coordinating
DMSO solvent molecules giving an overall distorted octahedral
Fig. 2 Molecular structure of {[Bi(MFHA)3]2·Me2CvO)} (3·0.5Me2CvO)
Only one of two independent molecules is shown; hydrogen atoms and
uncoordinated solvent molecules are omitted for clarity. Thermal ellip-
soids at 40% probability. Symmetry operator ’: 1 − x, 2 − y, 1 − z.
Selected bond lengths (Å) and angles (°): Bi(1)–O(1), 2.2586(15); Bi(1)–O(2),
2.4459(16); Bi(1)–O(4), 2.2918(15); Bi(1)–O(5), 2.4734(15); Bi(1)–O(7),
2.1747(16); Bi(1)–O(8), 2.4373(15); N(1)–O(1), 1.372(2); N(1)–C(2), 1.373(3);
N(2)–O(4), 1.368(2); N(2)–C(8), 1.317(3); N(3)–O(7), 1.383(2); N(3)–C(14),
1.333(3); C(2)–O(2), 1.273(3); C(8)–O(5), 1.270(3); C(4)–O(8), 1.262(3);
O(1)–Bi(1)–O(2), 67.48(5); O(4)–Bi(1)–O(5), 66.88(5); O(7)–Bi(1)–(O8),
69.31(5); Bi(1)–O(1)–Bi(1)’, 81.28(8); O(1)–Bi(1)–O1)’, 98.72(9).
Fig. 3 Molecular structure of {[Bi(BPHA)3]2·2EtOH} (7·EtOH). Hydrogen
atoms and uncoordinated solvent molecules are omitted for clarity.
Thermal ellipsoids at 40% probability. Symmetry operator ’: −x, 1 − y, −z.
Selected bond lengths (Å) and angles (°): Bi(1)–O(1), 2.2804(19); Bi(1)–
O(2), 2.5151(18); Bi(1)–O(3), 2.195(2); Bi(1)–O(4), 2.4994(18); Bi(1)–O(5),
2.2364(17); Bi(1)–O(6), 2.474(2); Bi(1)–O(1)’, 2.779(16); N(1)–O(3), 1.388
(3); N(1)–C(20), 1.251(3); N(4)–O(1), 1.390(3); N(4)–C(7), 1.342(3); N(7)–
O(5), 1.373(3); N(7)–C(33), 1.326(3); O(1)–Bi(1)–O(2), 66.07(6); O(3)–
Bi(1)–O(4), 67.71(7); O(5)–Bi(1)–O(6), 68.00(6); O(1)–Bi(1)–O(1)’,
72.30(6); Bi(1)–O(1)–Bi(1)’, 107.70(8).
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geometry for Bi(2). The hydrogen atom H(4N) in [4(DMSO)1.5·
0.5DMSO], which was placed in a calculated position con-
firmed by other analytical technique (see Experimental
section), makes a hydrogen-bond contact with the hydroxyl
group on the phenyl ring of the ligand [N(4H)–O(13) 1.896(5)
Å]. The C–O bond distances of the carbonyl groups [C(17)–O(8)
1.275(5) Å (SHA2−); C(24)–O(11) 1.288(5) Å (H-SHA)] and C–N
bonds [C(17)–N(3) 1.319(5) Å (SHA2−); C(24)–N(4) 1.297(5) Å
(H-SHA)] show little variation for the expected single versus
double bond characteristics of the di- and mono-anionic
ligands respectively. This most likely arises from an averaging
of the bonds through the crystal owing to the possibility of the
calculated NH proton being located on either of the ligands at
one time.
The full coordination environment of the Bi(III) centre in
[4(DMSO)1.5·0.5DMSO] is raised to seven through formation of
a linear polymeric chain (Fig. 5). The Bi–O bonds that propa-
gate the polymeric chain [Bi(2)–O(9)′ 2.605(3) Å] are signifi-
cantly longer than those in the asymmetric unit being more
indicative of a dative Bi–O bond length.
Recently we reported the structure of the first bismuth
hydroxamate complex.26 Interestingly, this proved to be a
unique Bi34 oxido-cluster [Bi34O22(BHA)22(H-BHA)14(DMSO)6]
10 resulting from the slow hydrolysis of [Bi2(BHA)3] in DMSO/
toluene solution. Complex [4(DMSO)1.5·0.5DMSO] is best com-
pared with 10 since both feature mono- and di-anionic hydro-
xamate ligands bound to the Bi(III) atoms. But unlike 10,
dissolution of complex 4 in DMSO does not result in hydrolysis
to give polynuclear oxido-clusters, perhaps due to the presence
of the hydroxyl group on the phenyl ring allowing through
hydrogen-bond stabilization resistance to hydrolysis and for-
mation of a more simple polymeric solid state.
Complexes 3·0.5Me2CvO and 7·EtOH display similar
hydroxamate O,O bi-dentate coordination modes to the
triphenyl antimony(V) complexes [SbPh3(H-BHA)MeO]2 9 and
[SbPh3(BPHA)Cl]2 10.
28 However, unlike 3·0.5Me2CvO and
7·EtOH the dimers in complexes 9 and 10 are formed through
weak hydrogen-bond interactions, which also serve to facilitate
their overall polymeric chain structure.
Hydrolysis and oxido-cluster formation
From our initial study we reported that the dinuclear bismuth(III)
benzohydroxamate complex [Bi2(BHA)3]∞ undergoes slow
hydrolysis in a DMSO/toluene solvent mixture to give crystals
of the unique {Bi34} oxido-cluster [Bi34O22(BHA)22(H-BHA)14
(DMSO)6].
26 This result indicated that the bismuth(III) hydrox-
amates as a compound class could be prone to hydrolysis.
Hydrolytic decomposition of bismuth complexes with
O-bound ligands is a well known phenomenon. For alkoxides
the close pKa values of H2O and the alcohol (conjugate acid)
coupled with the strong Lewis acidity of the Bi3+ cation make
the process to polynuclear oxido-clusters thermodynamically
favourable. However, it also can occur with carboxylates
and sulfonates,29–32 though with these the process is ligand
dependent and does not occur for every compound in these
two classes.
To investigate the stability of the bismuth(III) hydroxamates
complexes they were taken up in DMSO based solvent mixtures
and allowed to stand for several weeks. The only crystals which
appeared were consistent with those already described above
(3, 4 and 7), with the others producing fine precipitates. To
provide solutions of sufficient dilution to prevent short-term
crystallisation or precipitation each complex was taken up in
DMSO solution to give 2.0 mM concentration. These solutions
were then allowed to stand undisturbed over several weeks or
months until some fine precipitate began to appear. The same
solutions were examined both by Electrospray Mass Spectro-
metry (Table S2 ESI†) and Atomic Force Microscopy. Sample
Fig. 4 Molecular structure of {[Bi(SHA)(H-SHA)(DMSO)2][Bi(SHA)-
(H-SHA)(DMSO)]·DMSO}∞ [4(DMSO)1.5·0.5DMSO]. Only one of two inde-
pendent molecules is shown; hydrogen atoms (except NH) and uncoor-
dinated solvent molecules are omitted for clarity. Thermal ellipsoids at
40% probability. Selected bond lengths (Å) and angles (°): Bi(2)–O(8),
2.346(3); Bi(2)–O(9), 2.268(3); Bi(2)–O(11), 2.284(3); Bi(2)–O(12), 2.231
(3); Bi(2)–O(14), 2.748(3); Bi(2)–O(15), 2.710(6); N(3)–O(9), 1.382(4);
N(3)–C(17), 1.319(5); N(4)–O(12), 1.390(4); N(4)–C(24), 1.297(5); C(17)–
O(8), 1.275(5); C(24)–O(11), 1.288(5); O(13)–H(4N), 1.896(5); O(8)–Bi(2)–
O(9), 69.79(10); O(11)–Bi(2)–O(12), 70.18(10).
Fig. 5 Extended polymeric section of [4(DMSO)1.5·0.5DMSO] with
selected atom labeling. Symmetry operator ’: 1 − x, 2 − y, 1 − z. Selected
bond lengths (Å) and angles (°): Bi(2)–O(9)’ 2.605(3); Bi(2)–O(9)–Bi(2)’,
112.77(6); O(9)–Bi(2)–O(9)’, 67.23(8).
Dalton Transactions Paper
This journal is © The Royal Society of Chemistry 2015 Dalton Trans., 2015, 44, 16903–16913 | 16907
Pu
bl
ish
ed
 o
n 
09
 S
ep
te
m
be
r 2
01
5.
 D
ow
nl
oa
de
d 
by
 JA
M
ES
 C
O
O
K
 U
N
IV
ER
SI
TY
 o
n 
29
/1
0/
20
15
 0
1:
10
:1
4.
 
View Article Online
preparation details for AFM are provided in the Experimental
section.
The AFM height images are shown in Fig. 6 and demon-
strate the presence of particle-like features in dried samples.
The details for each sample are listed in Table 2.
In some samples, such as K[Bi(BHA)2] 9, the presence of
discrete, unaggregated particles is clear. However, for other
samples, such as [Bi(BPHA)3] 7, individual particles appear to
be lower in number, with clear evidence of surface aggregates.
This is most likely an effect of the drying procedure used in
sample preparation for AFM, where strong lateral capillary
forces tend to favour aggregation. It is unlikely that this reflects
the structure in solution/dispersion.
For comparison, from single crystal X-ray diffraction the
diameter of the [Bi34O22(BHA)22(H-BHA)14 (DMSO)6] oxido
cluster is 3.05 nm at its widest point.26 The bismuth subsalicy-
late oxido-cluster [Bi38O44(HSal)26(Me2CO)16(H2O)2] is 2.37 nm
wide.28 The smaller clusters [Bi9O7(HSal)13(Me2CO)5]
29 and
[Bi22O26(OSiMe2
tBu)14]
33 are both 1.72 nm at their widest
point, and so the diameter is as dependant on the ligand as
on the relative number of Bi atoms in the cage core. This
would suggest that images which show particle sizes with
diameters <0.5 nm the bismuth hydroxamato complexes
(1 and 6) show little signs of cluster formation or particle
aggregation. The mass spectra of both 1 and 6 display highly
charged low molecular mass oxido-species, e.g. [Bi4O2L2(OH)2-
(H2O)4]
4+, which would be <0.5 nm, with no evidence of larger
cages.
From the AFM images it is likely that complexes 3 (1.8 nm)
and 9 (3.5 nm) undergo hydrolysis to give polynuclear oxido-
clusters. Complex 3 shows the presence of both {Bi6} and {Bi9}
oxido-clusters; [Bi6O6L2(MeOH)(DMSO)2]
4+ and [Bi8O6L2(OH)6-
(MeOH)(H2O)20]
4+, which would match the 1.8 nm particles in
the AFM image. Unfortunately, complex 9, on dilution of the
solution with MeOH in preparation for recording the mass
spectrum, fully precipitated and so the spectrum only gave
peaks relating to the ligand with no Bi containing species
evident. Heights of 5 nm for 5 and 4 nm for 7 likely result
from the aggregation of smaller oxido-clusters. The mass spec-
trum of 5 displays m/z values corresponding to [Bi3L2(OH)-
(H2O)]
4+ and [Bi3OL(OH)(MeOH)2]
4+, while that of 7 indicates
species containing {Bi4} and {Bi6} species, e.g. [Bi6O4L4-
(H2O)2(MeOH)4]
4+. It may be expected that drying samples for
AFM imaging would induce additional aggregation for clusters
that experience attractive interactions, and this may explain
the surprisingly large size of the aggregates seen for 5 and 7.
Activity against Helicobacter pylori
We have reported previously on our investigations into the
antibacterial activity of the bismuth(III) benzohydroxamate
complexes [Bi(H-BHA)3] 2 and [Bi(BHA)(H-BHA)] 6.
26 Both
complexes showed remarkably low MIC values against three
laboratory strains of H. pylori: B128, 251 and 26695, ranging
from 0.05–0.78 μg mL−1 (0.08 to 1.26 µM) for 2 and
0.09–1.56 μg mL−1 (0.19 to 3.24 µM) for 6. These compare
favorably with other classes of bismuth(III) complexes which
typically have higher MIC values: bismuth (III) carboxylates and
thiobenzoates with MIC values of 6.25 μg mL−1 34,35 and
thioxoketones, MIC 3.12 μg mL−1.36 They are an orders of
magnitude more active than the current bismuth drugs used
to treat H. pylori, bismuth subsalicylate (BSS) MIC 12.5 μg
mL−1 and colloidal bismuth subcitrate (CBS) MIC 12.5 μg
mL−1.37–39 The only complexes which have shown comparably
low MIC values are bismuth(III) amino-arenesulfonates which
displayed MIC values against the three H. pylori strains of MIC
Fig. 6 AFM height images of bismuth clusters dried onto mica sub-
strates, where values refer to approximate cluster sizes obtained from
analysis of the AFM image: (a) K[Bi(BHA)2] 9: 3.5 nm; (b) [Bi(BPHA)3] 7:
4 nm; (c) [Bi(H-SHA)3] 1: <0.5 nm; (d) [Bi(AHA)(H-AHA)] 5: 5 nm; (e)
[Bi(MFHA)3] 3: 1.8 nm; (f ) [Bi(BHA)(H-BHA)] 6: <0.5 nm. The white scale
bar in each image represents 200 nm.
Table 2 Summary of AFM and sample data
Complex Code Height (nm) Sample age (weeks)
[Bi(H-SHA)3] 1 a <0.5 4
[Bi(MFHA)3] 3 b 1.8 16
[Bi(AHA)(H-AHA)] 5 c 5 4
Bi(BHA)(H-BHA)] 6 d <0.5 8
[Bi(BPHA)3] 7 e 4 24
K[Bi(BHA)2] 9 f 3.5 4
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0.05 μg mL−1 (0.06 μM), for example [Bi(O3S-(o-AB))3] from
ortho-aminobenzenesulfonic acid ((o-AB)SO3H).
40 Thus, the
motivation to exam the broader family of hydroxamato
complexes.
The minimum inhibitory concentration (MIC) of bismuth
complexes 1, 3–5 and 7–9 and their parent hydroxamic acids
were all assessed for their antibacterial activity against
H. pylori strains 26695, B128 and 251 using the Agar Diffusion
method and with compound concentrations ranging from
25 to 0.024 μg mL−1. The results are summarised in Table 3.
The table shows that the result initially observed for the
bismuth benzohydroxamate complexes is replicated across the
whole range of different bismuth hydroxamate complexes,
illustrating the effective powerful and bactericidal activity of
this family of complexes.
As expected, acetohydroxamic acid (H2-AHA) shows moder-
ately good activity against all three strains of the bacterium
(MIC of 6.25 μg mL−1 (83.26 μM)) since it is already known to
effectively inhibit the nickel containing urease essential for the
lifecycle of H. pylori.27 Its bismuth complex [Bi(AHA)(H-AHA)]
5 shows a magnification in this activity, exhibiting an MIC of
0.78 μg mL−1 (2.2 μM) for the 26695 strain and 1.56 μg mL−1
(4.58 μM) for strains B128 and 251, suggesting a synergistic
effect of the metal and ligand.
Surprisingly, the other hydroxamic acids showed no activity
towards the H. pylori strains below 25 μg mL−1. In contrast
their bismuth(III) complexes are highly effective at very low con-
centrations showing some marginal variations in MIC within
the overall class of compound.
Interestingly, there is a clear pattern within the family of
compounds for both the salicylhydroxamates and benzo-
hydroxamates in which the mono-anionic tris-hydroxamato
complexes are the most active compounds, followed by the
mixed anion complexes, with the di-anionic hydroxamato bis-
muthate complexes being marginally less effective. This is
illustrated by tracking activity against the 251 strain which
appears in the order: [Bi(H-SHA)3] (0.28 μM) < [Bi(SHA)-
(H-SHA)] (0.76 μM) < K[Bi(SHA)2] (1.41 μM) and [Bi(H-BHA)3]
(0.78 μM) < [Bi(BHA)(H-BHA)] (1.56 μM) < K[Bi(BHA)2]
(3.12 μM). The structural features of the complexes suggests
this pattern possibly reflects a reduction in their lipophilicity
as we move towards a more ionic species.
There appears to be little effect on the overall activity
from N-substitution since the complexes [Bi(MFHA)3] 3 and
[Bi(BPHA)3] 7 display similar activities to the other analogous
mono-anionic tris-hydroxamato complexes: 2.47 μM and
0.41 μM for 3 and 7 respectively against the 251 strain, though
it would suggest N-Ph promotes greater bactericidal activity
rather than N-Me substitution.
Mammalian cell toxicity
All the bismuth complexes were assessed for their toxicity
towards human skin fibroblast cells. The only compound
which showed any cytotoxic effect up to 100 μM was 2, at
which concentration it proved to be lethal to 94% of the cells,
but only 5% at 12.5 μM. All the other bismuth complexes were
non-toxic up to 100 μM, as were the hydroxamic acids them-
selves. The results are presented in the ESI.†
Conclusion
In this study seven new bismuth(III) hydroxamate complexes
were synthesized and fully characterized: tris-hydroxamato
complexes containing only mono-anionic ligands; [Bi-
(H-SHA)3] 1, [Bi(MFHA)3] 3 and [Bi(BPHA)3] 7, mixed-anion
complexes; [Bi(SHA)(H-SHA)] 4 and [Bi(AHA)(H-AHA)] 6, and
bismuthate complexes; K[Bi(SHA)2] 8 and K[Bi(BHA)2] 9. The
composition of each complex was established through NMR
and FT-IR studies, with the solid-state structure of three of
the complexes being determined through single crystal X-ray
diffraction; [Bi(MFHA)3]2·Me2CvO, {[Bi(SHA)(H-SHA)(DMSO)2]-
[Bi(SHA)(H-SHA)(DMSO)]·DMSO}∞ and [Bi(BPHA)3]2·2EtOH.
Stability studies using and comparing ES-MS and AFM indi-
cated that most of the complexes undergo slow hydrolysis over
several weeks in solution, generating either both low molecular
weight oxido species (1, 5–7) and larger polynuclear cages (3,
9). Both techniques proved wanting in definitive characteri-
sation but appeared at least complementary in indicating the
onset and extent of hydrolysis.
All the complexes and their parent acids were assessed for
the bactericidal activity against three strains of Helicobacter
pylori (26695, B128 and 251). Of the acids, only acetohydrox-
amic acid showed any activity at low concentrations (MIC
6.25 μg mL−1; 83.26 μM) while the others were found to be
non-toxic below 25 μg mL−1. In contrast, the bismuth(III)
hydroxamato complexes all showed excellent activity across all
Table 3 Minimum inhibitory concentrations (MIC μg mL−1 (μM)) of
bismuth compounds 1–9 and the parent hydroxamic acids measured
against three different strains of H. pylori
Compound
H. pylori strain
MIC μg mL−1 (μM)
26695 B128 251
H2-SHA >25
[Bi(H-SHA)3] 1 0.19 (0.28) 0.39 (0.59) 0.19 (0.28)
[Bi(SHA)(H-SHA)] 4 0.39 (0.76) 0.78 (1.52) 0.39 (0.76)
K[Bi(SHA)2] 8 0.78 (1.41) 1.56 (2.83) 0.78 (1.41)
H2-BHA >25
[Bi(H-BHA)3]
21 2 0.09 (0.14) 0.05 (0.08) 0.78 (1.26)
[Bi(BHA)(H-BHA)]21 6 0.19 (0.39) 0.09 (0.19) 1.56 (3.24)
K[Bi(BHA)2] 9 1.56 (3.00) 3.12 (6.01) 3.12 (6.01)
H2-AHA 6.25 (83.26)
[Bi(AHA)(H-AHA)] 5 0.78 (2.2) 1.56 (4.58) 1.56 (4.58)
H-MFHA >25
[Bi(MFHA)3] 3 1.56 (2.47) 1.56 (2.47) 1.56 (2.47)
H-BPHA >25
[Bi(BPHA)3] 7 0.39 (0.41) 0.39 (0.41) 0.39 (0.41)
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three strains of H. pylori (e.g. 0.28 μM for [Bi(H-SHA)3] to
6.01 μM for K[Bi(BHA)2] against strain 251) with only minor
variations in activity being both ligand and composition
dependant. These results suggest that the synergistic combi-
nation of Bi(III) metal with hydroxamate ligands has the poten-
tial to generate new and effective ‘trojan horse’ type
antibacterial agents.
Experimental section
Bismuth tert-butoxide, Bi(OtBu)3, was synthesized through a
metathesis reaction from the treatment of BiCl3 with potass-
ium tert-butoxide (KOtBu)3 in dried THF at 0 °C and sub-
sequently the residue is extracted with pentane in a soxhelette
extractor.41 Triphenyl bismuth (BiPh3) was synthesized accord-
ing to a literature procedure.42 Acetohydroxamic acid, salicyl-
hydroxamic acid, N-methylfurohydroxamic acid, N-benzoyl-N-
phenyl hydroxamic acid and benzohydroxamic acid were pur-
chased from Sigma-Aldrich Co. and TCI America, were used
without further purification. 1H-NMR spectra were recorded
using either a Bruker DRX 400 MHz or Bruker DPX 300 MHz
spectrometer as solutions in d6-DMSO. Multiplicities are
denoted as singlet (s), doublet (d), triplet (t), multiplet (m)
and broad (b), or combination where necessary. 13C
NMR spectra were recorded using either a Bruker DRX
400 MHz or DPX 300 MHz spectrometer as solutions in d6-
DMSO. Infrared Spectra (IR) as pure solid were recorded on a
Agilent Technologies Cary 630 FTIR. IR absorptions (Vmax) are
reported in units of wavenumbers (cm−1).
Mass spectra were recorded on a Micromass Platform Electro-
spray mass spectrometer at cone voltages as specified using a
DMSO/methanol or methanol solution as the mobile phase.
The ion peaks (m/z) and their assignments are listed. Elemen-
tal Analysis was performed by the Chemical & MicroAnalytical
Services Pty Ltd, Belmont, Victoria, Australia. Melting points
were measured on a Stuart Scientific SMP3 melting point
apparatus. All the solvents were purified before use. Tetra-
hydrofuran (THF) was distilled from sodium/benzophenone.
Pentane and ether were distilled from sodium. Ethanol and
methanol were dried over magnesium turnings prior to use
and stored over 4 Å MS under N2. All molecular sieves were
dried at 120 °C and allowed to cool under vacuum before use.
All reactions requiring anhydrous conditions were conducted
with oven-dried glassware under an atmosphere of dry nitro-
gen using a vacuum/nitrogen line and Schlenk techniques.
Atomic force microscopy (AFM) height images were made
using a Nanowizard 3 AFM from JPK in AC (intermittent
contact) mode. This instrument incorporates capacitive
sensors to ensure accurate reporting of height, z, and x–y
lateral distances. The cantilevers used were from Bruker
(model NCHV), and possessed nominal resonant frequencies
of 340 kHz and spring constants of ∼40 N m−1 respectively.
Images were obtained with a force set-point <1 nN. Post acqui-
sition, images were ‘flattened’ to arrange the scan lines in a
plane within the JPK image analysis software, and no further
manipulations were made. The height images shown convert
the normal (z) heights acquired by the AFM z-piezoelectric
drive capacitive feedback loop to a colour for ease of presen-
tation. The height scales of the images are (a–f ): 8.8, 6.6, 1.1,
12.5, 11.0 and 1.3 nm. Cluster heights were estimated by
taking line profiles across each image and calculating the
average feature height. Due to tip convolution, lateral dimen-
sions of small objects tend to be exaggerated in AFM imaging,
whereas heights are accurately reported by the instrument.
Bacterial strains and culture conditions
H. pylori strains 251, B128, and 26695 were routinely cultured
on horse blood agar (HBA) or in brain heart infusion broth
(BHI), supplemented with either 7.5% (v/v) fresh horse blood
or 10% (v/v) FCS,43 respectively. Culture media were further
supplemented with 155 µg L−1 polymyxin B, 6.25 µg L−1 vanco-
mycin, 3.125 µg L−1 trimethoprim, and 1.25 µg L−1 ampho-
tericin B.
Determination of the minimum inhibitory concentration
The MICs of bismuth complexes 1–7 were determined by the
agar dilution technique. All bismuth complexes were dissolved
in DMSO to give clear, colorless solutions of known concen-
tration. H. pylori cultures were incubated in BHI for 18 h,
shaking at 140 rpm at 37 °C under micro aerobic conditions.
Bacteria were pelleted, washed in phosphate-buffered saline,
then resuspended in BHI.44 Each suspension was adjusted to
give a fairly accurate density of 106 bacteria per mL. Aliquots
(10 mL) of these suspensions were then streaked onto HBA
plates containing doubling dilutions of the different concen-
trations of bismuth compounds, ranging in concentration
from 0.024 to 25 µg mL−1. Each compound was tested along
with the free ligands in equal concentrations. The MICs of the
different compounds were determined by assessment of the
plates after incubation for 3–5 days at 37 °C.
X-ray data
Crystallographic data for compound 7 was obtained on an
OXFORD Gemini Ultra equipped with an OXFORD Cryo-
systems 700 Cryostream and cooled to 123(1) K. Data was
collected with monochromatic (graphite) Mo Kα radiation (λ =
0.71073 Å) and processed using the CrysAlisProv 1.171.34.3 45
software; Lorentz, polarization and absorption corrections
(multi-scan) were applied. Crystallographic data for com-
pounds 3 and 4 were obtained on a Bruker X8 APEXII CCD
diffractometer46 equipped with an OXFORD Cryosystems 700
Cryostream and cooled to 123(1) K. Data was collected with
monochromatic (graphite) Mo Kα radiation (λ = 0.71073 Å) and
processed using the Bruker Apex2 v2012.2.0 software; Lorentz,
polarization and absorption corrections (multi-scan –
SADABS)47 were applied. Compounds 3, 4 and 7 were solved
and refined with SHELX-97.48 All non-hydrogen atoms were
refined with anisotropic thermal parameters unless otherwise
indicated and hydrogen atoms were placed in calculated posi-
tions using a riding model with C–H = 0.95–0.98 Å and Uiso(H)
= xUiso(C), x = 1.2 or 1.5. Data for 3, 4 and 7 has been deposited
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with the Cambridge Crystallographic Database with CCDC
number 1046081, 1046082 and 1046083 respectively.
Synthesis and characterization of bismuth(III) hydroxamates
1–9
From salicylhydroxamic acid (H2-SHA)
[Bi(H-SHA)3], 1. Solvent reflux: in a Schlenk flask and under
inert conditions, a mixture of triphenyl bismuth (0.22 g,
0.5 mmol) and salicylhydroxamic acid (0.23 g, 1.5 mmol) in
ethanol or toluene (10 mL) was heated to reflux for 24 hours.
This resultant mixture was allowed to cool to room tempera-
ture before the precipitate was collected by filtration. Any
excess triphenyl bismuth was removed by washing the precipi-
tate with small aliquots (5 mL) of ethanol. The precipitate was
then dried under vacuum.
Solvent-free: in a Schlenk flask and under inert conditions,
a solid mixture of triphenyl bismuth (0.22 g, 0.5 mmol) and
salicylhydroxamic acid (0.23 g, 1.5 mmol) was heated at 120 °C
for 1 hour. On cooling unreacted triphenyl bismuth was
removed by washing the precipitate with small amounts of
ethanol and toluene (5 mL). The precipitate was then dried
under vacuum.
Yields: 0.21 g, 63% (toluene reflux); 0.19 g, 57% (ethanol
reflux); 0.23 g, 69% (solvent-free). Melting point: 225–226 °C
(decomp.). FT-IR (cm−1): 661 (Vs, ring in plane bend), 744 (m,
CH-out of plane bend), 909 (Vs, NO), 1248 (m, C–O), 1440 (m,
C–N), 1561 (m, CvO), 1596 (w, CvN), 3066 (brd, Phe-OH),
3281 (brd, NH). 1H NMR (400 MHz, d6-DMSO): δ 6.83 (t, 3H,
Hd), 6.91 (d, 3H, Hc), 7.28 (bs, 3H, Hb), 7.66 (d, 3H, Ha), 9.89
(s, 0.5H, Hi), 11.96 (s, 3.8H, Hh). 13C NMR (100 MHz, d6-
DMSO): 116.3 (Cd), 118.5 (Cc), 127.2 (Ca), 131.6 (Cf), 157.6 (Ce),
166.3 (Cg). Elemental analysis; (BiC21H18N3O9), Calc (Found):
C 37.91 (37.83), H 2.73 (2.90), N 6.32 (6.27) %. Mass spectrum,
(ESI+): 513.1 [BiL2]
+, 722.0 [BiL3 + K(H2O)]
+, (ESI−) 152.2 [L]−,
510.9 [BiL2]
−; (where LH2 = H2-SHA).
Bi(SHA)(H-SHA)] 4. A solution of bismuth tert-butoxide
(0.21 g, 0.5 mmol) in THF (10 mL) was added under inert
atmosphere to a clear solution of salicylhydroxamic acid
(0.23 g, 1.5 mmol) in THF (20 mL) at −80 °C. The reaction
mixture was then allowed to warm slowly to room temperature
overnight. Removal of volatiles under vacuum left a light
yellow coloured solid, which was washed with dry ethanol to
remove any unreacted acid and/or bismuth butoxide. Crystals
suitable for X-ray diffraction were grown from DMSO solution.
Yield: 0.20 g, 78%. Melting point: 206–208 °C (decomp.).
FT-IR (cm−1): 745 (m, CH-out of plane bend), 910 (Vs, NO),
1244 (m, C–O), 1445 (m, C–N), 1565 (m, CvO), 1593 (m,
CvN), 3070 (brd, Ph(OH)), 3229 (brd, NH). 1H NMR (300 MHz,
d6-DMSO): δ 6.80 (t, 2H, H
b), 6.91 (d, 2H, Hd), 7.27 (bs, 2H,
Hc), 7.65 (d, 2H, Ha), 9.35 (s, 0.4H, Hi), 12.21 (s, 2.8H, Hh). 13C
NMR (100 MHz, d6-DMSO): 116.1 (C
d), 118.4 (Cc), 127.1 (Ca),
131.2 (Cf), 157.4 (Ce), 166.4 (Cg). Elemental analysis;
(BiC14H11N2O6 + C4H8O), Calc (Found): C 37.00 (36.79), H 3.38
(3.28), N 5.14 (4.79) %. Mass spectrum, (ESI+): 513.2 [Bi(LH)(L)
+ H]+, 535.1 [Bi(LH)(L) + Na]+, (ESI−) 152.1 [L]−, 510.9 [BiL2]
−;
(where LH2 = H2-SHA).
Crystal data for 4: Bi2N4O16C37H49; Mr = 1352.00; triclinic;
space group: P1ˉ; a = 7.7836(4), b = 12.4644(7), c = 23.1300(11);
α = 87.484(2); β = 85.407(2); γ = 84.557(2); V = 2225.2(2)Å3; Z =
2, reflections collected/unique: 46 278/12 791 (Rint = 0.0434);
R1 values (I > 2σ(I)) = 0.0331; wR(F
2) values (I > 2σ(I)) = 0.0744;
R1 values (all data) = 0.0462; wR(F
2) values (all data) = 0.0789;
GOF = 1.046.
K[Bi(SHA)2] 8. The reaction was carried out under nitrogen
atmosphere using pre-dried solvents. A solution of potassium
tert-butoxide (0.11 g, 1.0 mmol) in THF (10 mL) was added to a
solution of [Bi(SHA)(H-SHA)] 4 (0.51 g, 1.0 mmol) in THF
(10 mL) at −80 °C. The reaction mixture was then allowed to
warm slowly to room temperature overnight. All volatiles were
removed under vacuum leaving behind a pale yellow precipi-
tate, which was washed with ethanol.
Yield: 0.32 g, 63%. Melting point: 194–196 °C (decomp.).
FT-IR (cm−1): 664 (Vs, ring in plane bend), 751 (m, CH-out of
plane bend), 910 (NO), 1251 (m, C–O), 1593 (m, CvN), 3056
(brd, Ph(OH)). 1H NMR (300 MHz, d6-DMSO): δ 6.63 (bs, 2H,
Hb), 6.74 (bs, 2H, Hd), 7.08 (bs, 2H, Hc), 7.60 (d, 2H, Ha), 8.38
(s, 0.4H, Hi), 13.06 (s, 1.5H, Hh). 13C NMR (100 MHz, d6-
DMSO): 114.7 (Cb), 117.3 (Cd), 121.3 (Cc), 126.4 (Ca), 128.6 (Cf),
157.4 (Ce), 170.2 (Cg). Elemental analysis; (BiC14H10KN2O6 +
1/2(C4H8O)), Calc (Found): C 32.77 (33.11), H 2.41 (2.83),
N 4.78 (5.10) %. Mass spectrum, (ESI+): 551.0 [(Bi(L2)K) + H]
+,
(ESI−): 152.0 [L]−, 510.9 [BiL2]
−; (where LH2 = H2-SHA).
From benzohydroxamic acid (H2-BHA)
K[Bi(BHA)2] 9. All manipulations were carried out under
nitrogen atmosphere with predried solvents. A solution of pot-
assium tert-butoxide (0.11 g, 1.0 mmol) in THF (10 mL) was
added to a solution of bismuth benzohydroxamate [Bi(BHA)-
(H-BHA)] 6 (0.48 g, 1.0 mmol) in THF (10 mL) at −80 °C and
stirred overnight. The reaction mixture was then allowed to
warm slowly to room temperature overnight. All volatiles were
removed under vacuum leaving behind a yellow precipitate
which was washed with ethanol.
Yield: 0.34 g, 67%. Melting point: 304–305 °C (decomp.).
FT-IR (cm−1): 679 (Vs, ring in plane bend), 773 (m, CH-out of
plane bend), 898 (NO), 1306 (m, C–O), 1442 (m, C–N), 1561 (w,
CvO), 1596 (m, CvN). 1H NMR (300 MHz, d6-DMSO): δ 7.21
(m, 6H, Hb, c, d), 7.82 (bs, 4H, Ca, e). 13C NMR (75 MHz, d6-
DMSO): 126.1 (Ca, e), 126.7 (Cb, d), 127.6 (Cc), 137.4 (Cf ), 167.8
(Cg). Elemental analysis; (BiC14H10KN2O4), Calc (Found):
C 32.44 (32.67), H 1.94 (2.17), N 5.40 (5.22) %. Mass spectrum,
(ESI+): 481.0 [BiL2]
+, 519.0 [Bi (L)(LH) + K]+, 541.0 [(Bi (L2)K) +
Na]+, (ESI−): 136.0 [L]−, 478.9 [BiL2]
−; (where LH2 = H2-BHA).
From acetohydroxamic acid (H2-AHA)
[Bi(AHA)(H-AHA)] 5. All manipulations were carried out
under nitrogen atmosphere with predried solvents. A 10 mL
THF solution of bismuth tert-butoxide (0.21 g, 0.5 mmol) was
added to a solution of acetohydroxamic acid (0.11 g,
1.5 mmol) in THF (20 mL) at −80 °C. The reaction mixture was
allowed to warm to room temperature overnight. Removal of
all volatiles under vacuum left a white solid which was washed
with dry ethanol to remove any unreacted acid and/or bismuth
butoxide.
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Yield: 0.13 g, 73%. Melting point: 231–232 °C (decomp).
FT-IR (cm−1): 1084 (Vs, NO), 1280 (m, C–O), 1313 (m, C–N),
1425 (m, CH3 def.), 1534 (m, CvO), 1595 (m, CvN), 2916 (m,
CH3–alkyl strech), 3163 (brd, NH).
1H NMR (300 MHz, d6-
DMSO): δ 1.77 (s, 6H, Ha), 11.62 (s, 1H, Hc). 13C NMR (75 MHz,
d6-DMSO): 18.1 (C
a), 164.4 (Cb). Elemental analysis;
(BiC4H7N2O4), Calc (Found): C 13.49 (13.43), H 1.98 (2.15), N
7.87 (7.82) %. Mass spectrum, (ESI+): 107.1 [L + H(MeOH)]+,
139.1 [L + H (MeOH)2]
+, 357.1 2 [Bi(LH)(L) + H]+, 379.1 [Bi(LH)-
(L) + Na]+, (ESI−) 74.1 [L]−, 355.2 [BiL2]
−; (where LH2 = H2-
AHA).
From N-methylfurohydroxamic acid (H-MFHA)
[Bi(MFHA)3] 3. Solvent reflux: in a Schlenk flask and under
inert conditions, a mixture of triphenyl bismuth (0.22 g,
0.5 mmol) and N-methylfurohydroxamic acid (0.21 g,
1.5 mmol) in ethanol or toluene (10 mL) was heated to reflux
for 24 hours. This mixture was then allowed to cool to room
temperature before the precipitate was collected by filtration.
An remaining triphenyl bismuth was removed by washing the
precipitate with small amounts of ethanol (5 mL). The precipi-
tate was then dried under vacuum.
Solvent-free: in a Schlenk flask and under inert conditions,
a mixture of triphenyl bismuth (0.22 g, 0.5 mmol) and
N-methylfurohydroxamic acid (0.21 g, 1.5 mmol) was heated at
100 °C for 1 hour. This remaining solid was allowed to cool to
room temperature and any remaining triphenyl bismuth was
removed by washing with small amounts of ethanol (5 mL)
and toluene (5 mL). The precipitate was then dried under
vacuum.
A 10 mL THF solution of N-methylfurohydroxamic acid
(0.21 g, 1.5 mmol) was added to a solution of bismuth tert-
butoxide (0.21 g, 0.5 mmol) in THF (20 mL) at −80 °C. The reac-
tion mixture was left to reach room temperature while stirring
overnight. Removal of solvent under vacuum left a light yellow
solid, which was washed with ethanol to remove any unreacted
acid and/or bismuth butoxide.
Crystals suitable for X-ray diffraction were grown from
acetone or ethanol solution.
Yield: 0.19 g, 60% (toluene reflux); 0.17 g, 55% (ethanol
reflux), 0.21 g, 67% (solvent-free), 0.30 g, 95% (in THF).
Melting point: 165–167 °C (decomp.). FT-IR (cm−1): 959 (Vs,
NO), 1401 (Vs, C–N) 1552 (m, CvO), 2931 (m, CH sym. CH3).
1H NMR (300 MHz, d6-DMSO): δ 3.58 (s, 9H, H
a), 6.64 (q, 3H,
Hd), 6.93 (dd, 3H, Hc), 7.88 (q, 3H, He). 13C NMR (100 MHz,
d6-DMSO): 42.4 (C
a), 111.7 (Cd), 114.9 (Cc), 144.9 (Ce), 146.0
(Cb), 153.7 (Cg). Elemental analysis; (BiC18H18N3O9), Calc
(Found): C 34.35 (34.52), H 2.88 (3.01), N 6.68 (6.54) %. Mass
spectrum, (ESI+): 488.9 [BiL2]
+, 651.9 [BiL3 + Na]
+ (ESI−) 140.1
[L]−; (where LH = H-MFHA).
Crystal data for 3: Bi4N12O37C75H78; Mr = 2575.41; triclinic;
space group: P1ˉ; a = 10.8304(3), b = 11.6831(4), c = 17.0183(5);
α = 83.5330(10); β = 75.7080(10); γ = 83.6910(10); V = 2065.90
(11)Å3; Z = 1, reflections collected/unique: 67 867/12 227 (Rint =
0.0327); R1 values (I > 2σ(I)) = 0.0190; wR(F
2) values (I > 2σ(I)) =
0.0386; R1 values (all data) = 0.0268; wR(F
2) values (all data) =
0.0405; GOF = 1.029.
From N-phenylbenzohydroxamic acid (H-BPHA)
[Bi(BPHA)3] 7. The reaction was carried out under nitrogen
atmosphere using predried solvents. A 10 mL THF solution of
N-phenylbenzohydroxamic acid (0.32 g, 1.5 mmol) was added
to a solution of bismuth tert-butoxide (0.21 g, 0.5 mmol) in
THF (20 mL) at −80 °C. The reaction was allowed to reach
room temperature while stirring overnight. Removal of all vola-
tiles under vacuum left a yellow solid which was washed with
ethanol to remove any unreacted acid and/or bismuth butox-
ide. Crystals suitable for X-ray diffraction were grown from
acetone or ethanol solution.
Yield: 0.29 g, 68%. Melting point: 148–149 °C (decomp.).
FT-IR (cm−1): 691 (Vs, ring in plane bend), 766 (m, CH-out of
plane bend), 916 (Vs, NO), 1420 (Vs, C–N), 1530 (m, CvO).
1H NMR (300 MHz, d6-DMSO): δ 7.05 (m, 6H, H
i, i′), 7.17 (m,
9H, Hj, h, h′), 7.26 (bs, 12H, He, e′, f, f′), 7.33 (m, 3H, Hd). 13C
NMR (75 MHz, d6-DMSO): 126.7 (C
i,i′), 127.7 (Ch,h′), 128.1 (Cj),
128.3 (Cf, f′), 129.1 (Ce, e′), 129.8 (Cd), 134.1 (Cc), 143.7 (Cb),
163.8 (Cg). Elemental analysis; (BiC39H30N3O6), Calc (Found):
C 55.19 (55.26), H 3.58 (3.70), N 4.97 (4.93) %. Mass spectrum,
(ESI+): 286.0 [LH + H (THF)]+, 494.0 [BiL + H (THF)]+; (where
LH = C13H11O2N).
Crystal data for 7: Bi2N6O13C80H66; Mr = 1737.35; monocli-
nic; space group: P121/c1; a = 14.1095(8), b = 18.8537(11), c =
15.4923(7); β = 99.868(4); V = 4060.2(4) Å3; Z = 2, reflections col-
lected/unique: 27 627/12 635 (Rint = 0.0363); R1 values (I > 2σ(I))
= 0.0319; wR(F2) values (I > 2σ(I)) = 0.0672; R1 values (all data) =
0.0469; wR(F2) values (all data) = 0.0711; GOF = 1.032.
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